NCT00261508 – Efficacy And Safety Of Risperidone In The Treatment Of Children With Autistic Disorder And Other Pervasive Developmental Disorders: A Canadian, Multicenter, Double-Blind, Placebo-Controlled Study Posted on March 31, 2016 by tsuperadmin -
Risperidone in the treatment of behavioural disturbances in patients with Alzheimer’s dementia: a double-blind placebo-controlled trial Posted on March 31, 2016 by tsuperadmin -
NCT00249158 – Risperidone in the Treatment of Behavioural and Psychological Signs and Symptoms in Dementia (BPSSD): a Multicentre, Double-blind, Placebo-controlled Parallel-group Trial Posted on March 31, 2016 by tsuperadmin -
NCT00937040 – A Placebo Controlled Double-Blind, Parallel Group, Individualizing Dosing Study Optimizing Treatment of Adults With Attention Deficit Hyperactivity Disorder to an Effective Response With OROS Methylphenidate Posted on March 9, 2016 by tsuperadmin -
NCT01551290 – A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Infliximab in Chinese Subjects With Active Ulcerative Colitis Posted on February 25, 2016 by tsuperadmin -
NCT00085748 – A Randomized, 6-Week Double-Blind, Placebo-Controlled Study With an Optional 24-Week Open-Label Extension to Evaluate the Safety and Tolerability of Flexible Doses of Paliperidone Extended Release in the Treatment of Geriatric Patients With Schizophrenia Posted on January 22, 2016 by tsuperadmin -
A Phase 3, Randomized, Open-Label, Comparative Study of DOXIL/CAELYX® versus Topotecan HCl in Patients with Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy Posted on November 19, 2015 by tsuperadmin -
NCT00653952 – A Phase 3, Randomized, Open-Label, Comparative Study of CAELYX® versus Paclitaxel HCl in Patients with Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy Posted on November 19, 2015 by tsuperadmin -
Efficacy in the rHuEPO (Epoetin Alfa) in the Critically Ill Patient: A Randomized, Double Blind, Placebo-Controlled trial Posted on October 29, 2015 by tsuperadmin -
NCT00078039 – Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia Posted on October 27, 2015 by tsuperadmin -
The YODA Project